These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2935482)

  • 41. Oral acyclovir: a pill to easy to swallow?
    Barriere SL
    Clin Pharm; 1984; 3(6):655. PubMed ID: 6542477
    [No Abstract]   [Full Text] [Related]  

  • 42. [The value of acyclovir via oral route].
    Evenou P; Revuz J
    Ann Dermatol Venereol; 1986; 113(5):483-6. PubMed ID: 3579122
    [No Abstract]   [Full Text] [Related]  

  • 43. Acyclovir and other chemotherapy for herpes group viral infections.
    Balfour HH
    Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allergic drug eruption secondary to intravenous acyclovir.
    Schuster J; Fabri M; Eming S; Hunzelmann N
    Acta Derm Venereol; 2008; 88(2):196-8. PubMed ID: 18311465
    [No Abstract]   [Full Text] [Related]  

  • 45. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutical effects of intravenous acyclovir administration in patients affected with genital herpes.
    Corbino N; Guglielmino S; Ciravolo L; Tempera G
    Chemioterapia; 1987 Jun; 6(2 Suppl):667-70. PubMed ID: 2855617
    [No Abstract]   [Full Text] [Related]  

  • 47. Diagnosis and treatment of genital herpes infections.
    Mertz GJ
    Infect Dis Clin North Am; 1987 Jun; 1(2):341-66. PubMed ID: 3332794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions.
    Al-Waili NS
    Med Sci Monit; 2004 Aug; 10(8):MT94-8. PubMed ID: 15278008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.
    Carney O; Ross E; Ikkos G; Mindel A
    Genitourin Med; 1993 Dec; 69(6):457-9. PubMed ID: 8282300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
    Lebrun-Vignes B; Bouzamondo A; Dupuy A; Guillaume JC; Lechat P; Chosidow O
    J Am Acad Dermatol; 2007 Aug; 57(2):238-46. PubMed ID: 17416440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acyclovir: a respite, not a cure, for primary genital herpes infections.
    Halpern JS
    J Emerg Nurs; 1984; 10(5):268-71. PubMed ID: 6207330
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of topical acyclovir.
    Pagano JS
    J Am Acad Dermatol; 1983 May; 8(5):756-8. PubMed ID: 6863640
    [No Abstract]   [Full Text] [Related]  

  • 54. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
    Molin L; Ruhnek-Forsbeck M; Svennerholm B
    Scand J Infect Dis Suppl; 1991; 80():33-9. PubMed ID: 1666444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asymptomatic herpes simplex virus shedding from the genital tract whilst on suppressive doses of oral acyclovir.
    Bowman CA; Woolley PD; Herman S; Clarke J; Kinghorn GR
    Int J STD AIDS; 1990 May; 1(3):174-7. PubMed ID: 1964599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group.
    Goldberg LH; Kaufman R; Kurtz TO; Conant MA; Eron LJ; Batenhorst RL; Boone GS
    Arch Dermatol; 1993 May; 129(5):582-7. PubMed ID: 8481018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acyclovir.
    Schrager A
    J Urol; 1983 Feb; 129(2):393-4. PubMed ID: 6682150
    [No Abstract]   [Full Text] [Related]  

  • 58. Adverse reactions to acyclovir: topical, oral, and intravenous.
    Arndt KA
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):188-90. PubMed ID: 3339141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acyclovir use and its surveillance in a general population.
    Johnson RE; Mullooly JP; Valanis BG; Andrews EB; Tilson HH
    DICP; 1990 Jun; 24(6):624-8. PubMed ID: 2360339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contact allergy to acyclovir.
    Valsecchi R; Imberti G; Cainelli T
    Contact Dermatitis; 1990 Nov; 23(5):372-3. PubMed ID: 2151378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.